MedPath
TGA Approval

PADCEV enfortumab vedotin 30 mg powder for injection vial (367410)

367410

PADCEV enfortumab vedotin 30 mg powder for injection vial

Astellas Pharma Australia Pty Ltd

July 7, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/3d3621dc4835dbb2c7c773aa7cde6936.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/428e5ef3d0feaff5ed3396ffda899038.pdf

Active Ingredients

enfortumab vedotin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PADCEV enfortumab vedotin 30 mg powder for injection vial (367410) - TGA 批准文号 | MedPath